Monitoring proliferative activities of hormone-like odorants in human breast cancer cells by gene transcription profiling and electrical impedance spectroscopy

Biosensors and Bioelectronics

Volumn 50, Issue , 2013, Pages 431-436

  Pick, Horst ^a   Terrettaz, Samuel ^a   Baud, Olivia ^a   Laribi, Ouahiba ^a   Brisken, Cathrin ^a   Vogel, Horst ^a  

^a EPFL   (Switzerland)

Author keywords

Breast cancer; Cell proliferation; Electrical cell substrate impedance sensing (ECIS); Estrogen receptor (ER ); Estrogenic chemicals; Signal transduction; Synthetic sandalwood odorants; Transcription

Indexed keywords

BREAST CANCER; ELECTRICAL CELLS; ESTROGEN RECEPTOR; ESTROGENIC CHEMICALS; SYNTHETIC SANDALWOOD ODORANTS;

CELL PROLIFERATION; CELL SIGNALING; CELLS; GENE EXPRESSION REGULATION; SIGNAL TRANSDUCTION; SIGNALING;

TRANSCRIPTION;

ESTROGEN RECEPTOR ALPHA;

ANALYTIC METHOD; ARTICLE; CANCER CELL; CELL ADHESION; CELL COUNT; CELL PROLIFERATION; CELL STRAIN MCF 7; CELL STRUCTURE; CONCENTRATION RESPONSE; CONTROLLED STUDY; ELECTRICAL CELL SUBSTRATE IMPEDANCE SENSING; ELECTROCHEMICAL IMPEDANCE SPECTROSCOPY; ELECTRODE; ESTROGEN ACTIVITY; GENE EXPRESSION PROFILING; HUMAN; HUMAN CELL; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; TRANSCRIPTION REGULATION;

BREAST CANCER; CELL PROLIFERATION; ELECTRICAL CELL SUBSTRATE IMPEDANCE SENSING (ECIS); ESTROGEN RECEPTOR Α (ERΑ); ESTROGENIC CHEMICALS; SIGNAL TRANSDUCTION; SYNTHETIC SANDALWOOD ODORANTS; TRANSCRIPTION;

BIOSENSING TECHNIQUES; BREAST NEOPLASMS; CELL LINE, TUMOR; CELL PROLIFERATION; DIELECTRIC SPECTROSCOPY; ESTROGEN RECEPTOR ALPHA; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; ODORS; SANTALUM; SIGNAL TRANSDUCTION; TRANSCRIPTOME;

EID: 84880964678     PISSN: 09565663     EISSN: 18734235     Source Type: Journal    
DOI: 10.1016/j.bios.2013.06.052     Document Type: Article

References (36)

1. Abba M.C., Hu Y., Sun H., Drake J.A., Gaddis S., Baggerly K., Sahin A., Aldaz C.M. BMC Genomics 2005, 6:37.
2. Agatonovic-Kustrin S., Turner J.V., Glass B.D. Journal of Pharmaceutical and Biomedical Analysis 2008, 48:369-375.
3. Ayyanan A., Laribi O., Schuepbach-Mallepell S., Schrick C., Gutierrez M., Tanos T., Lefebvre G., Rougemont J., Yalcin-Ozuysal O., Brisken C. Molecular Endocrinology 2011, 25:1915-1923.
4. Bitsch N., Dudas C., Korner W., Failing K., Biselli S., Rimkus G., Brunn H. Archives of Environmental Contamination and Toxicology 2002, 43:257-264.
5. Brisken C., Heineman A., Chavarria T., Elenbaas B., Tan J., Dey S.K., McMahon J.A., McMahon A.P., Weinberg R.A. Genes and Development 2000, 14:650-654.
6. Brisken C., O'Malley B. Cold Spring Harbor Perspectives in Biology 2010, 2:a003178.
7. Brzozowski A.M., Pike A.C., Dauter Z., Hubbard R.E., Bonn T., Engstrom O., Ohman L., Greene G.L., Gustafsson J.A., Carlquist M. Nature 1997, 389:753-758.
8. Busser B., Sancey L., Brambilla E., Coll J.L., Hurbin A. Biochimica et Biophysica Acta 2011, 1816:119-131.
9. Charles A.K., Darbre P.D. Journal of Applied Toxicology 2009, 29:422-434.
10. Chen Y.J., Hung C.M., Kay N., Chen C.C., Kao Y.H., Yuan S.S. Cancer Letters 2012, 319:223-231.
11. Ciarloni L., Mallepell S., Brisken C. Proceedings of the National Academy of Sciences of the United States of America 2007, 104:5455-5460.
12. Conzen S.D. Molecular Endocrinology 2008, 22:2215-2228.
13. Creighton C.J., Cordero K.E., Larios J.M., Miller R.S., Johnson M.D., Chinnaiyan A.M., Lippman M.E., Rae J.M. Genome Biology 2006, 7:R28.
14. Eker B., Meissner R., Bertsch A., Mehta K., Renaud P. PLoS One 2013, 8:e57423.
15. Evans R.M., Scholze M., Kortenkamp A. PLoS One 2012, 7:e43606.
16. Fang H., Tong W., Perkins R., Soto A.M., Prechtl N.V., Sheehan D.M. Environmental Health Perspectives 2000, 108:723-729.
17. Frasor J., Stossi F., Danes J.M., Komm B., Lyttle C.R., Katzenellenbogen B.S. Cancer Research 2004, 64:1522-1533.
18. Giacinti L., Claudio P.P., Lopez M., Giordano A. Oncologist 2006, 11:1-8.
19. Giaever I., Keese C.R. Proceedings of the National Academy of Sciences of the United States of America 1991, 88:7896-7900.
20. Graham J.D., Clarke C.L. Breast Cancer Research 2002, 4:187-190.
21. Hah N., Danko C.G., Core L., Waterfall J.J., Siepel A., Lis J.T., Kraus W.L. Cell 2011, 145:622-634.
22. Hecker M., Hollert H. Environmental Sciences Europe 2011, 23:15.
23. Hu Z.Z., Kagan B.L., Ariazi E.A., Rosenthal D.S., Zhang L., Li J.V., Huang H., Wu C., Jordan V.C., Riegel A.T., Wellstein A. PLoS One 2011, 6:e20410.
24. Kariagina A., Xie J., Leipprandt J.R., Haslam S.Z. Hormones and Cancer 2010, 1:229-244.
25. Kininis M., Kraus W.L. Nuclear receptor signaling 2008, 6:e005.
26. Marino M., Galluzzo P., Ascenzi P. Current Genomics 2006, 7:497-508.
27. Metivier R., Penot G., Hubner M.R., Reid G., Brand H., Kos M., Gannon F. Cell 2003, 115:751-763.
28. Pick H., Jankevics H., Vogel H. Journal of Molecular Biology 2007, 374:1213-1223.
29. Pick H., Etter S., Baud O., Schmauder R., Bordoli L., Schwede T., Vogel H. Journal of Biological Chemistry 2009, 284:30547-30555.
30. Rimkus G.G., Wolf M. Chemosphere 1996, 33:2033-2043.
31. Rotroff D.M., Dix D.J., Houck K.A., Knudsen T.B., Martin M.T., McLaurin K.W., Reif D.M., Crofton K.M., Singh A.V., Xia M., Huang R., Judson R.S. Environmental Health Perspectives 2013, 121:7-14.
32. Schreurs R.H., Sonneveld E., Jansen J.H., Seinen W., van der Burg B. Toxicological Sciences 2005, 83:264-272.
33. Soto A.M., Sonnenschein C., Chung K.L., Fernandez M.F., Olea N., Serrano F.O. Environmental Health Perspectives 1995, 103(Suppl. 7):113-122.
34. Tarantola M., Marel A.K., Sunnick E., Adam H., Wegener J., Janshoff A. Integrative Biology (Cambridge) 2010, 2:139-150.
35. Thomas C., Gustafsson J.A. Nature Reviews Cancer 2011, 11:597-608.
36. Yu N., Atienza J.M., Bernard J., Blanc S., Zhu J., Wang X., Xu X., Abassi Y.A. Analytical Chemistry 2006, 78:35-43.